Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Arnav Mehta

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0313-2848; OpenAlex author ID A5000794179. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
57
Papers, trials and grants by year

2020: 3 papers · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 2 papers

Papers 8

  1. Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-25-1117↗
  2. Immune and stromal features of durable complete response to radiation and dual immune checkpoint blockade in pancreatic cancer Co-author DOI 10.64898/2026.08.06.26359422↗
  3. Development of an artificial intelligence-derived histologic signature associated with adjuvant gemcitabine treatment outcomes in pancreatic cancer. Co-author DOI 10.1016/j.xcrm.2023.101013↗
  4. Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment. Co-author DOI 10.1038/s41588-022-01134-8↗
  5. Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial. Co-author DOI 10.1038/s43018-021-00269-7↗
  6. Single-nucleus and spatial transcriptomics of archival pancreatic cancer reveals multi-compartment reprogramming after neoadjuvant treatment Co-author DOI 10.1101/2020.08.25.267336↗
  7. The present and future of systemic and microenvironment-targeted therapy for pancreatic adenocarcinoma. Co-author DOI 10.21037/apc-2020-pda-05↗
  8. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma. Co-author DOI 10.3322/caac.21626↗

Closest collaborators

The 25 strongest of 57 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Colin D. Weekes · 5 shared papers, 2020–2026 · strength 0.63
  2. Dana Pe'er · 2 shared papers, 2026 · strength 0.41
  3. William L. Hwang · 3 shared papers, 2020 · strength 0.36
  4. David Tsai Ting · 3 shared papers, 2020–2026 · strength 0.34
  5. Theodore Sunki Hong · 3 shared papers, 2020–2026 · strength 0.34
  6. David P. Ryan · 3 shared papers, 2020–2026 · strength 0.34
  7. Jennifer Yon-Li Wo · 3 shared papers, 2020–2026 · strength 0.34
  8. Lawrence Scott Blaszkowsky · 2 shared papers, 2021–2026 · strength 0.27
  9. Aparna R. Parikh · 2 shared papers, 2021–2026 · strength 0.27
  10. Akimasa Hayashi · 1 shared paper, 2026 · strength 0.23
  11. Wungki Park · 1 shared paper, 2026 · strength 0.23
  12. Eileen Mary O'Reilly · 1 shared paper, 2026 · strength 0.23
  13. Alejandro Jiménez-Sánchez · 1 shared paper, 2026 · strength 0.23
  14. Jungeui Hong · 1 shared paper, 2026 · strength 0.23
  15. Christine A. Iacobuzio–Donahue · 1 shared paper, 2026 · strength 0.23
  16. Joseph Wang Franses · 1 shared paper, 2026 · strength 0.18
  17. Julie L. Koenig · 1 shared paper, 2026 · strength 0.18
  18. Hannah Johnson Roberts · 1 shared paper, 2026 · strength 0.18
  19. Thomas Adam Abrams · 1 shared paper, 2026 · strength 0.18
  20. Ryan Jin-hyung Park · 1 shared paper, 2026 · strength 0.18
  21. Sarah Slater · 1 shared paper, 2026 · strength 0.18
  22. Sarah Kang · 1 shared paper, 2026 · strength 0.18
  23. Matthew B.B. Yurgelun · 1 shared paper, 2026 · strength 0.18
  24. Brian Matthew Wolpin · 1 shared paper, 2026 · strength 0.18
  25. Joseph Douglas Mancias · 1 shared paper, 2026 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.